C

CCS Medical

Home delivery medical supplies with support

Insurance Verification Representative

Full-TimeDeadline 9/11/27
No salary listed
Mid
Remote in USA+1 moreMore locations: Houston, TX, USA
RemoteResidents of Alaska, California, Colorado, Delaware, Hawaii, Idaho, Maine, Montana, Nevada, New Hampshire, New York, North Dakota, Rhode Island, South Dakota, Vermont, Washington, Wyoming, and Illinois are not eligible.
Medical, Clinical & VeterinaryClinical Support & Patient Administration

About the job

Requirements
  • A high school diploma is required.
  • One year of medical insurance verification-related experience or an equivalent combination of education and experience is required.
  • One year of customer service experience is required.
  • Strong working knowledge of billing procedures, insurance reimbursement procedures, and HCPC codes is required.
  • Ability to analyze and correct accounts receivable problems is required.
  • Proficiency in Microsoft Outlook, Word, Excel, PowerPoint, and general computer literacy is required.
  • Knowledge of government and commercial insurance payers and the documentation required before claim submission is required.
  • Ability to understand medical records documents is required.
  • Ability to maintain confidentiality when handling sensitive information is required.
  • Ability to maintain regular, predictable, and consistent attendance and flexibility to meet department needs is required.
  • Position may require evening and weekend availability.
Responsibilities
  • Make outbound calls to insurance companies to verify insurance benefits.
  • Evaluate insurance coverage to determine policy compatibility with the program and recommend appropriate products based on patient needs and insurance coverage.
  • Verify, review, document, and complete insurance verifications accurately and efficiently.
  • Identify and initiate documentation needs and requests to support timely billing of services and communication with appropriate teams.
  • Review patient accounts and determine appropriate actions needed to collect payment.
  • Review claims and perform claim corrections and submissions to a new carrier based on new plan verification.
  • Follow Medicare, Medicaid, Health Insurance Portability and Accountability Act, and private insurance regulations and requirements.

About the company

C

CCS Medical

View
Website

CCS Medical delivers home-based medical supplies for people with chronic conditions. Its offerings include continuous glucose monitoring (CGM) systems, insulin pumps, wound care products, urology and ostomy supplies, and prescription medications, with orders often paid through insurance and shipped directly to patients' homes. The service works by providing products alongside assistance from healthcare specialists who help patients use them correctly and safely, including Certified Diabetes Care Education Specialists, Wound Care Specialists, and Licensed Pharmacists. What sets CCS Medical apart is its combination of a wide product catalog, in-home delivery, and access to specialized clinical support, backed by healthcare accreditation that ensures quality and compliance. The company aims to make it easy for patients to obtain the supplies they need and to support better chronic-condition management through education, guidance, and convenient access to medications and devices.

Company Size

1,001-5,000

Company Stage

Late Stage VC

Total Funding

$33M

Headquarters

Saint Petersburg, Florida

Founded

1994

Get referred to CCS Medical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • May 19 2026 ISPOR research says longitudinal coaching sustains CGM outcomes beyond initiation.
  • April 28 2026 CCS deployed enterprise-wide agentic AI with Deloitte and Adaptive ML.
  • CMS kept 2026 Medicare CGM coverage under Part B for DME suppliers.

What critics are saying

  • January 1 2026 Humana pushed CGMs into pharmacies, weakening CCS's DME channel.
  • Curcio qui tam litigation filed July 14 2023 still targets CCS Medical.
  • If pharmacy distribution wins, CCS's DME economics erode and the business becomes a commodity.

What makes CCS Medical unique

  • July 2026 research links CCS DME CGM distribution to higher adherence than pharmacies.
  • PropheSee, launched June 11 2024, predicts CGM nonadherence with 85% accuracy in 90 days.
  • CCS's 30-year chronic-care specialization spans diabetes, wounds, urology, and ostomy.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Company Match
  • Paid Vacation
  • Paid Holidays
  • Wellness Program
  • Mental Health Support
  • Remote Work Options
  • Hybrid Work Options
  • Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

5%
HIT Consultant
Mar 25th, 2025
Dme Providers Lead To Better Cgm Adherence And Lower Healthcare Costs Compared To Pharmacies

What You Should Know:– New research published in Clinical Diabetes, a peer-reviewed journal of the American Diabetes Association, reveals that patients receiving continuous glucose monitors (CGM) through durable medical equipment (DME) providers demonstrate significantly higher adherence and lower healthcare costs compared to those using pharmacy channels.– The study, titled “Impact of Continuous Glucose Monitoring Sourcing on Real-World Adherence and Healthcare Costs: A Comparative Analysis by Insurance Type,” challenges the notion that expanding CGM access through pharmacies improves patient outcomes and cost-effectiveness.Link Between Clinical Glucose Monitor Distribution Channel and Patient OutcomesCCS, a provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions, conducted this groundbreaking research, which highlights that adding the pharmacy as a new channel for CGM distribution, alongside the established DME provider channel, may be having unintended negative consequences.While previous studies have shown higher adherence and lower costs with DME providers, this latest research is unique in that it examined differences between commercial and Medicare Advantage insurance populations. The findings highlight that the channel decision for medical supply distribution significantly impacts outcomes and healthcare expenditures.Key findings from the research include:Improved Adherence: Patients receiving CGM supplies through the DME channel demonstrated greater adherence to their prescribed therapy. At 12 months: Medicare/Medicare Advantage patients: 78% adherence with DME vs. 64% with pharmacy. Commercially insured patients: 60% adherence with DME vs. 48% with pharmacy.Patients receiving CGM supplies through the DME channel demonstrated greater adherence to their prescribed therapy

HIT Consultant
Jan 6th, 2025
The Obesity Conversation: Moving Beyond Stigma And Shame

Dr. Arti Masturzo, Chief Medical Officer at CCS The conversation about what makes a “healthy” body has never been simple. Throughout every era of history, people have resorted to calling each other too fat, too thin, too tall, too short, too curvy, too muscular, or too lanky, often to reinforce power structures or achieve social agendas. And every single time, we fall for it. We spend billions upon billions of dollars on products, potions, and procedures to help us get a little closer to that perfect body — whatever that means.It’s very easy to get caught in the false narratives of our rigid, macro mindsets on health and weight that try to say that you’re either thin, toned, and happy — or you’re fat, sick, and miserable.  In the wake of the Olympics this past summer, which tends to reignite these controversies, a wonderful image is making the rounds on the internet. Photographer Howard Schatz produced it for his 2002 book, Athlete, and shows the incredible variety of body sizes and shapes of elite athletes across dozens of sports, each of whom has taken advantage of their unique biological gifts to succeed at a very specific task.  Nothing does a better job of showing that health, performance, weight, and happiness can look a little different for everyone — except maybe viral sensation and USA rugby medalist, Ilona Maher, whose empowering responses to criticisms about her body have taken the internet by storm.   As an internal medicine physician and healthcare executive focused on improving chronic conditions (as well as a woman, a mother, a cancer survivor, and someone who has struggled to find their own balance of weight and wellness), I feel like the healthcare community is entering a pivotal moment in the conversation around health, happiness, and body condition.How can we, as healthcare leaders and caregivers, send the right messages about health and wellness — especially when set against a complicated background of an obesity and diabetes epidemic, the advent of GLP-1s, influencers promoting “anti-diet” movements and “thinspiration,” and a mental health crisis that is leading more and more people to feel hopeless and anxious about their bodies?The key is to shift our fundamental thinking on the relationships between health, appearance, performance, longevity, and joy from being our best selves in every respect. That starts by bringing empathy, respect, and positivity back into the way we discuss our bodies, both in everyday life and in the healthcare setting.Modifying the way clinicians address “modifiable” factors in body conditionThe human body is designed to eat and retain weight from doing so

HIT Consultant
Jun 18th, 2024
What Will It Take To Achieve Value From Digitally Enabled Diabetes Care?

Tony Vahedian, CEO at CCSA report from the Peterson Health Technology Institute (PHTI) found that many digital diabetes management platforms aren’t providing meaningful ROI for patients or the health system as a whole.  Users of common technologies only see small, incremental clinical benefits, such as 0.23%–0.60% point reduction in HbA1c when compared to traditional care. Meanwhile, some health plans and employers are actually seeing an increase in overall costs as spending on these platforms can often exceed savings from improved clinical outcomes.This is not news that anyone wanted to hear, especially in light of the enormous health plan investment in digital health platforms during the COVID-19 pandemic. We have learned some incredible lessons from implementing and adapting digital health solutions quickly during the pandemic and can use these learnings to drive additional innovation in our new normal.Why the disappointing disconnect? Because timing is everything when trying to change the status quo, and the pandemic hit at a critical juncture in the maturity curve of the digital health environment. While many of these platforms were on the right track to use virtual innovations for reducing the fragmentation and frustration of the face-to-face patient experience, the sudden urgency to shift everything fully online to meet basic care needs forced some of these issues to the back burner. As a result, some platforms are finding it difficult to loop back and address the gaps that have been unintentionally baked into their current models.Now that the urgency of the COVID era has lessened, however, it’s time to regroup. Digital health innovators — and the providers and health plans they serve — should take this moment to reflect on solving the fundamental pain points of the patient experience, regardless of the channel, and then decide how to strategically apply digital tools to further improve the organic, fundamental relationships upon which all of healthcare is built.Think in terms of relationshipsHealthcare has built-in buy-in from consumers, but some people still think it’s not their “job” to take a leadership role in their health and well-being — it’s the job to be done by their provider and health plan. Worse yet, far too many healthcare stakeholders fail to realize that having this “captive” consumer audience doesn’t automatically mean they are engaged, educated, and empowered to own and lead their health journey. Digital health innovators cannot assume that checking off a to-do task in an app is an indicator of optimal adherence or that ordering medications and/or supplies regularly means the consumer completely understands how to use them to manage their health. When digital care platforms rely too heavily on this transactional approach as a proxy for engagement, they lose the essence of what it means to live with a chronic condition

HIT Consultant
Jun 11th, 2024
Ccs Unveils Prophesee: Ai Predictive Model Predicts And Improves Cgm Adherence In Diabetes Management

CCS Unveils PropheSee: AI Predictive Model Predicts and Improves CGM Adherence in Diabetes Management. by Syed Hamza Sohail 06/11/2024 Leave a Comment. What You Should Know:–              CCS — leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions — today announced PropheSee™ a new, AI-powered predictive model for healthcare organizations focused on improving adherence in the population of people that have been prescribed a continuous glucose monitoring (CGM) device to help manage their diabetes.–              In addition to improved clinical outcomes, health plans and risk-bearing providers can also realize savings of up to $2,200 per patient per year from this increase in CGM adherence.PropheSee Model Boosts Adherence Rates in High-Risk Patient Cohorts by 50%CCS has observed a remarkable 50% increase in adherence rates among high-risk patient cohorts following the deployment of its new predictive model, PropheSee. This significant improvement is attributed to tech-enabled, personalized interventions based on risk classification, combined with the timely delivery of patient-specific information and insights that support long-term therapy adherence.CCS leverages a comprehensive dataset that includes decades of proprietary patient behavior data, offering a far more holistic view of an individual’s health and well-being compared to traditional claims data, which is often delayed and incomplete. Additionally, the integration of patient-level Social Determinants of Health (SDOH) data provides a more complete understanding of each patient. This enables healthcare organizations to proactively identify those most at risk of discontinuing therapy.As a leading chronic care management company, CCS provides clinical solutions and home-delivered medical supplies for individuals with chronic conditions, particularly diabetes

Business Wire
Mar 7th, 2024
New Report: People Living With Diabetes Have False Hope In Glp-1S, Strong Demand For More Engagement And Education

DALLAS--(BUSINESS WIRE)--CCS — leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions — today announced a new report revealing 57% of individuals living with diabetes in the United States think GLP-1 weight loss drugs alone may be a silver bullet for helping achieve their health goals. CCS, in collaboration with independent market research firm PureSpectrum, surveyed more than 1,500 individuals living with diabetes to understand their attitude as it relates to an array of timely issues, including growing demand for GLP-1 weight loss drugs and whether people living with type 2 diabetes feel like their provider relationship is setting them up for success when it comes to self-management of their chronic disease. “GLP-1 weight loss drugs alone are not a silver bullet when it comes to improving the health and well-being of those living with diabetes,” said Dr. Arti Masturzo, Chief Medical Officer at CCS. “These drugs do offer hope for those living with diabetes and others looking to manage obesity, but they should be prescribed in conjunction with hands-on personalized education and coaching, as well as the appropriate medical device technology needed to streamline diabetes self-management.”. Beyond GLP-1 weight loss drugs, a broad lack of focus on patient education and coaching for people living with diabetes was also highlighted in this report